Current issues for anti-malarial drugs to control P. falciparum malaria

Current Molecular Medicine
D SchellenbergC Roper

Abstract

Successful malaria control depends heavily on efficacious anti-malarial drugs for the treatment of malaria. Artesunate-containing Combination Treatments (ACT) are increasingly recommended as first line malaria treatment in endemic countries, but implementation of this recommendation is limited by the small number of available and affordable co-formulated anti-malarial drugs. In recent years Intermittent Preventive Treatment has been recommended for malaria control in pregnancy and has been shown to be of potential public health importance in the prevention of malaria and anaemia in children. The use of drugs for malaria treatment or prevention is associated with the development of resistance and recent advances in molecular biology facilitate the evaluation of the impact on drug resistance of new drug-based strategies. This review concentrates on the challenges surrounding the use of ACT, the current understanding of IPT in infants and the use of molecular approaches to enhance our understanding of the effects of interventions on the spread of drug resistance.

Citations

Sep 15, 2011·Parasitology Research·Yanhui ZhangXin-Zhuan Su
Sep 1, 2006·Journal of Medicinal Chemistry·Steven J BurgessDavid H Peyton
Jan 22, 2010·Journal of Medicinal Chemistry·Simeon AndrewsDavid H Peyton
Jun 19, 2008·The Journal of Antimicrobial Chemotherapy·Véronique SinouDaniel Parzy
Apr 23, 2009·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Haythem A SaadehMohammad S Mubarak
Nov 24, 2007·Expert Opinion on Biological Therapy·Jiraprapa Wipasa, Eleanor M Riley
Aug 19, 2007·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·A Crampton, T Vanniasinkam
Aug 24, 2006·Molecular Microbiology·Katerina Artavanis-TsakonasHidde L Ploegh
May 27, 2015·European Journal of Medicinal Chemistry·Suvarna ShenviG Chandrasekara Reddy
Jun 20, 2007·Nature Chemical Biology·Barbara M SchmidtIlya Raskin
Aug 22, 2017·Frontiers in Microbiology·Xue BaiMingyuan Liu
Jun 1, 2013·Journal of Behavioral Addictions·Edo ShoninMark D Griffiths
Jul 10, 2018·Monatshefte für chemie·Joanna Fedorowicz, Jarosław Sączewski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

Current Treatment Options in Cardiovascular Medicine
Prakash C Deedwania, Natalia Volkova
Nature Chemical Biology
Barbara M SchmidtIlya Raskin
© 2021 Meta ULC. All rights reserved